Dear Respected Users:
Hotbit is scheduled to list INJ (Injective Protocol) and launch【Hotbit’s INJ Investment Product】.
Expected Rate Of Annualized Return:10%(The rate of interest is determined by the daily updates of Hotbit’s official website);Redemption Period:T+1.
Deposit function launches at:2020.10.21 04:00 AM UTC
Trading function launches at:2020.10.21 04:00 AM UTC
Trading Pairs:INJ/USDT, INJ/BTC
【Hotbit users exclusively enjoy “Minus Maker Means Minus Transaction Fee” mechanism. By placing and settling any maker order, the user will enjoy 0 transaction fee and an extra 0.05% of the trading volume of his/her maker order as reward!】
Project Name:Injective Protocol
Abbreviation:INJ
Project Introduction:
Injective Protocol is a universal Decentralized Finance (DeFi) protocol for cross-chain derivatives trading across a plethora of financial products such as perpetual swaps, futures, and spot trading.The Injective Chain is implemented as a Cosmos SDK module, built with Ethermint (EVM on Tendermint). It utilizes a Tendermint-based Proof-of-Stake to facilitate cross chain derivatives trading across Cosmos, Ethereum, and many other layer-1 protocols.Injective Protocol is collision resistant and utilizes Verifiable Delay Function (VDF) to prevent front-running.
Token type: ERC-20
Total supply: 100,000,000 INJ
Official Website: https://injectiveprotocol.com/
Contract address: https://etherscan.io/token/0xe28b3b32b6c345a34ff64674606124dd5aceca30
Risk warning
The investment on cryptocurrency projects is subject to high market risks.Please make your investments cautiously. Hotbit will make best efforts to choose the cryptocurrency projects with high quality,but Hotbit will not be responsible for any of your investment losses.
Thank you for your support!
Yours truly
Hotbit Team
About us :
Hotbit’s Official Website: https://www.hotbit.io/
Telegram : https://t.me/Hotbit_English
Twitter: https://twitter.com/Hotbit_news
Facebook: https://www.facebook.com/hotbitexchange/
Medium: https://medium.com/@hotbit
Comments
0 comments
Article is closed for comments.